NEWSNATIONNOW (Rob Taub) - More US employers dropping coverage for weight-loss drugs in 2027
Demand for Ozempic, Wegovy and similar drugs is soaring, but some employers say the cost is becoming too much to absorb.
NPR (Bram Sable-Smith) - If a Lyme disease vaccine gets approved, how would it go over? We asked hunters
Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?
NPR (Sydney Lupkin) - Want obesity drugs covered by insurance? Telehealth companies have a big say
Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to limit spending on the drugs.
ABCNEWS - Supreme Court rejects appeals from drugmakers over Medicare price negotiations
The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government
NYTIMES (Mark Miller) - Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know
What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss.
NPR - Doctors worry about FDA scrutiny of RSV shots to protect babies
The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The drugmakers behind them maintain they're safe.
YOUTUBE (NewsNation) - Weight-loss users sue drugmakers, citing adverse effects
As the use of weight loss drugs becomes more popular, over 4,000 users say they’ve experienced serious health effects and filed lawsuits against drugmakers.